New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic

Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading

RCT Acquires Translational Drug Development, LLC

Tucson, Ariz. & Scottsdale, Ariz. / June 4, 2020
Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization.
TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies.Continue reading

Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

“Lilly scientists delivered the first doses of our potential #COVID19 antibody treatment, flown to hospitals in several U.S. cities to start the world’s first human study of this kind of therapy to fight COVID infections.” @lillypad

  • First patients have been dosed in a Phase 1 study of LY-CoV555, the lead antibody from Lilly’s collaboration with AbCellera
  • The placebo-controlled study will assess safety and tolerability in patients hospitalized with COVID-19 with results anticipated by the end of June
  • Should Phase 1 results show the antibody can be safely administered, Lilly will initiate a Phase 2 proof of concept study to assess efficacy in vulnerable populationsContinue reading